Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). p. 1049. ISSN 1462-0324

Metadata

Authors/Creators:
  • McCarthy, EM
  • Sutton, E
  • Nesbit, S
  • Parker, B
  • Jayne, D
  • Griffiths, B
  • Isenberg, DA
  • Rahman, A
  • Gordon, C
  • D’Cruz, DP
  • Rhodes, B
  • Lanyon, P
  • Vital, EM https://orcid.org/0000-0003-1637-4755
  • Yee, C-S
  • Edwards, CJ
  • Teh, L-S
  • Akil, M
  • McHugh, NJ
  • Zoma, A
  • Bruce, IN
  • British Isles Lupus Assessment Group Biologics Register,
Commentary on: McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). pp. 1041-1043. ISSN 1462-0324
Dates:
  • Published: 1 June 2017
  • Published (online): 22 May 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2018 14:53
Last Modified: 25 Sep 2018 15:04
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kex218

Commentary/Response Threads

Share / Export

Statistics